Reshape Biotech
PrivateLast Round
Series A
Apr 9, 2024
Est. Valuation
$1.79M
Total Funding Raised
$29.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Reshape Biotech operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Series A round in April 2024.
Reshape Biotech is a biotechnology company that develops an AI and robotics-powered platform to automate laboratory experiments for the food, agriculture, and biotech sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Workflow Automation, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reshape Biotech Comparables
Compare Reshape Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singer Instruments | 80% | |
| Microtechnix | 79% | |
| CyteSi, Inc. | 79% |
For institutional investors. Book with your work email.
Reshape Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2024 | ||||
| Seed | Feb 9, 2023 | ||||
| Pre Seed | May 23, 2021 | ||||
| Accelerator | Mar 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reshape Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Astanor Ventures | Series A |
| R7 Partners | Series A |
| Y Combinator | Accelerator, Seed, Series A, Pre Seed |
| Sherpa Capital | Series A, Seed |
| Look Up Ventures | Seed |
| FundersClub | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 7, 2026
Added The Clockwork Group SAS, a biotechnology startup, as a customer.
- Dec 8, 2025
Added Ventera Bio, a biotechnology startup, as a customer.
For institutional investors. Book with your work email.
Reshape Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reshape Biotech's valuation, stock price, and market status.
Is Reshape Biotech a public or private company?
Reshape Biotech is a private company.
What is the current stock price of Reshape Biotech?
Reshape Biotech is a private company, so its shares have no public market price. Caplight tracks Reshape Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reshape Biotech worth (valuation)?
Reshape Biotech's valuation is estimated at $1.8M based on funding round data.
Can I buy Reshape Biotech stock?
Reshape Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reshape Biotech's last funding round?
Reshape Biotech's most recent funding round was Series A on April 9, 2024.
Who are the main investors in Reshape Biotech?
Key investors in Reshape Biotech include Astanor Ventures, Sherpa Capital, FundersClub.
Will Reshape Biotech IPO soon?
No public IPO plans have been announced for Reshape Biotech.
How can I track Reshape Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Reshape Biotech's shares on secondary markets.